tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

Background Morbidity and mortality rates for pertussis in infants are high because disease often occurs before the onset of… (More)

Background Maternal antibodies to pertussis can hamper infant immune responses to pertussis vaccines. The effect a maternal… (More)

The objective was to determine if there is an association between maternal body mass index (BMI) and maternal and neonatal… (More)

IMPORTANCE Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine could… (More)

OBJECTIVE To assess the acceptability of a Tdap vaccination program for partners of pregnant women. STUDY DESIGN Pregnant women… (More)

OBJECTIVE Pertussis causes significant morbidity among adults, children, and especially infants. Since 2006, pertussis… (More)

BACKGROUND The effect of maternal Tdap vaccination on infant immunologic responses to routine pediatric vaccines is unknown… (More)

BACKGROUND Infants <2 months of age are at highest risk of pertussis morbidity and mortality. Until recently, the US Advisory… (More)

BACKGROUND In 2006, the Advisory Committee on Immunization Practices recommended tetanus, diphtheria, acellular pertussis (Tdap… (More)

OBJECTIVE Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) is recommended for adults… (More)